Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

A Pilot Study of Interpersonal Psychotherapy for Depressed Women with Breast Cancer.

Blanco C, Markowitz JC, Hershman DL, Levenson JA, Wang S, Grann VR.

Am J Psychother. 2014;68(4):489-95.

PMID:
26453348
2.

Portrayal of complementary and alternative medicine for cancer by top online news sites.

Price A, Grann VR.

J Altern Complement Med. 2012 May;18(5):487-93. doi: 10.1089/acm.2011.0110. Epub 2012 May 2.

PMID:
22551076
3.

Defining variations in survival of BRCA1 and BRCA2 mutation carriers.

Grann VR, Parsons RE.

JAMA. 2011 Oct 12;306(14):1597-8. doi: 10.1001/jama.2011.1476. No abstract available.

PMID:
21990304
4.

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.

Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, Grann VR, Hershman DL.

J Clin Oncol. 2011 Jun 20;29(18):2534-42. doi: 10.1200/JCO.2010.33.3179. Epub 2011 May 23.

5.

High-deductible plans: What if you can't afford your share?: Comment on "Health care use and decision-making among lower-income families in high-deductible health plans".

Grann VR.

Arch Intern Med. 2010 Nov 22;170(21):1925. doi: 10.1001/archinternmed.2010.417. No abstract available.

PMID:
21098353
6.

Prophylactic pancreatectomy for intraductal papillary mucinous neoplasm does not negatively impact quality of life: a preliminary study.

Lee MK, DiNorcia J, Pursell LJ, Holden MM, Tsai WY, Stevens PD, Goetz N, Grann VR, Chabot JA, Allendorf JD.

J Gastrointest Surg. 2010 Nov;14(11):1847-52. doi: 10.1007/s11605-010-1346-0. Epub 2010 Sep 8.

PMID:
20824365
7.

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.

Grann VR, Patel PR, Jacobson JS, Warner E, Heitjan DF, Ashby-Thompson M, Hershman DL, Neugut AI.

Breast Cancer Res Treat. 2011 Feb;125(3):837-47. doi: 10.1007/s10549-010-1043-4. Epub 2010 Jul 20.

8.

Erasing barriers to minority participation in cancer research.

Grann VR.

J Womens Health (Larchmt). 2010 May;19(5):837-8. doi: 10.1089/jwh.2010.1985. No abstract available.

PMID:
20392157
9.

Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

Chabot JA, Tsai WY, Fine RL, Chen C, Kumah CK, Antman KA, Grann VR.

J Clin Oncol. 2010 Apr 20;28(12):2058-63. doi: 10.1200/JCO.2009.22.8429. Epub 2009 Aug 17.

10.

Breast cancer-related preferences among women with and without BRCA mutations.

Grann VR, Patel P, Bharthuar A, Jacobson JS, Warner E, Anderson K, Warner E, Tsai WY, Hill KA, Neugut AI, Hershman D.

Breast Cancer Res Treat. 2010 Jan;119(1):177-84. doi: 10.1007/s10549-009-0373-6. Epub 2009 Mar 26.

PMID:
19322653
11.

Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean.

Grann VR, Ziv E, Joseph CK, Neugut AI, Wei Y, Jacobson JS, Horwitz MS, Bowman N, Beckmann K, Hershman DL.

Br J Haematol. 2008 Oct;143(2):288-93. doi: 10.1111/j.1365-2141.2008.07335.x. Epub 2008 Aug 15.

12.

Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.

Hershman DL, McBride RB, Eisenberger A, Tsai WY, Grann VR, Jacobson JS.

J Clin Oncol. 2008 Jul 1;26(19):3159-65. doi: 10.1200/JCO.2007.14.1242.

PMID:
18591554
13.

Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa.

Yaeger R, Avila-Bront A, Abdul K, Nolan PC, Grann VR, Birchette MG, Choudhry S, Burchard EG, Beckman KB, Gorroochurn P, Ziv E, Consedine NS, Joe AK.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1329-38. doi: 10.1158/1055-9965.EPI-07-2505.

14.

Neutropenia in 6 ethnic groups from the Caribbean and the U.S.

Grann VR, Bowman N, Joseph C, Wei Y, Horwitz MS, Jacobson JS, Santella RP, Hershman DL.

Cancer. 2008 Aug 15;113(4):854-60. doi: 10.1002/cncr.23614.

15.

Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.

Hershman DL, Buono D, McBride RB, Tsai WY, Joseph KA, Grann VR, Jacobson JS.

J Natl Cancer Inst. 2008 Feb 6;100(3):199-206. doi: 10.1093/jnci/djm320. Epub 2008 Jan 29.

PMID:
18230795
16.

Arsenic exposure and anemia in Bangladesh: a population-based study.

Heck JE, Chen Y, Grann VR, Slavkovich V, Parvez F, Ahsan H.

J Occup Environ Med. 2008 Jan;50(1):80-7. doi: 10.1097/JOM.0b013e31815ae9d4.

PMID:
18188085
17.

Predictors of survival after hepatic resection among patients with colorectal liver metastasis.

Wang X, Hershman DL, Abrams JA, Feingold D, Grann VR, Jacobson JS, Neugut AI.

Br J Cancer. 2007 Dec 17;97(12):1606-12. Epub 2007 Dec 11.

18.

Racial disparities in treatment and survival of male breast cancer.

Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, Hershman DL.

J Clin Oncol. 2007 Mar 20;25(9):1089-98.

PMID:
17369572
19.

Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients.

Doyle JJ, Neugut AI, Jacobson JS, Wang J, McBride R, Grann A, Grann VR, Hershman D.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):82-93. Epub 2007 Mar 2.

PMID:
17336464
20.

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.

J Natl Cancer Inst. 2007 Feb 7;99(3):196-205.

PMID:
17284714
21.

Inequality of care and cancer survival.

Grann VR.

Virtual Mentor. 2007 Jan 1;9(1):48-51. doi: 10.1001/virtualmentor.2007.9.1.pfor3-0701. No abstract available.

22.

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.

Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI.

Cancer. 2006 Dec 1;107(11):2581-8.

23.

Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma.

Grann VR, Hershman D, Jacobson JS, Tsai WY, Wang J, McBride R, Mitra N, Grossbard ML, Neugut AI.

Cancer. 2006 Oct 1;107(7):1530-41.

24.

Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival.

Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI.

Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1353-60. Epub 2006 Jun 9.

PMID:
16765531
25.

Completion rates of adjuvant chemotherapy for colon cancer: a historical perspective.

Grann VR, Muggia FM.

J Natl Cancer Inst. 2006 May 3;98(9):570-1. No abstract available.

PMID:
16670377
26.

Breast biopsy and race/ethnicity among women without breast cancer.

Jacobson JS, Grann VR, Hershman D, Troxel AB, Li H, Neugut AI.

Cancer Detect Prev. 2006;30(2):129-33. Epub 2006 Apr 18.

PMID:
16621329
27.

Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.

Neugut AI, Matasar M, Wang X, McBride R, Jacobson JS, Tsai WY, Grann VR, Hershman DL.

J Clin Oncol. 2006 May 20;24(15):2368-75. Epub 2006 Apr 17.

PMID:
16618946
28.

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.

Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI.

Breast Cancer Res Treat. 2006 Oct;99(3):313-21. Epub 2006 Apr 1.

PMID:
16583264
29.

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.

Anderson K, Jacobson JS, Heitjan DF, Zivin JG, Hershman D, Neugut AI, Grann VR.

Ann Intern Med. 2006 Mar 21;144(6):397-406.

PMID:
16549852
30.

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.

Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL.

J Clin Oncol. 2005 Dec 1;23(34):8597-605.

PMID:
16314622
31.

Racial disparities in treatment and survival among women with early-stage breast cancer.

Hershman D, McBride R, Jacobson JS, Lamerato L, Roberts K, Grann VR, Neugut AI.

J Clin Oncol. 2005 Sep 20;23(27):6639-46.

PMID:
16170171
32.

Barriers to minority participation in breast carcinoma prevention trials.

Grann VR, Jacobson JS, Troxel AB, Hershman D, Karp J, Myers C, Neugut AI.

Cancer. 2005 Jul 15;104(2):374-9.

33.

Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review.

Jacobson JS, Grann VR, Gnatt MA, Hibshoosh H, Austin JH, Millar WS, Neugut AI.

Integr Cancer Ther. 2005 Jun;4(2):156-67. Review.

PMID:
15911928
34.

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.

Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI.

Cancer. 2005 Jun 1;103(11):2241-51.

35.

The case for randomized trials in cancer treatment: new is not always better.

Grann A, Grann VR.

JAMA. 2005 Feb 23;293(8):1001-3. No abstract available.

PMID:
15728172
36.

Can an herbal agent replace estrogen for hot flashes?

Jacobson JS, Grann VR.

Cancer Invest. 2004;22(4):645-7. No abstract available.

PMID:
15565822
37.

Facilitating cancer research using natural language processing of pathology reports.

Xu H, Anderson K, Grann VR, Friedman C.

Stud Health Technol Inform. 2004;107(Pt 1):565-72.

PMID:
15360876
38.

Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer.

Hershman D, Jacobson JS, McBride R, Mitra N, Sundararajan V, Grann VR, Neugut AI.

Gynecol Oncol. 2004 Aug;94(2):540-9.

PMID:
15297201
39.

Waiting time in prostate cancer.

Neugut AI, Grann VR.

JAMA. 2004 Jun 9;291(22):2757-8. No abstract available.

PMID:
15187059
40.

Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy.

Matasar MJ, Sundararajan V, Grann VR, Neugut AI.

Drugs Aging. 2004;21(2):113-33. Review.

PMID:
14960128
41.

Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study.

Hershman D, Fleischauer AT, Jacobson JS, Grann VR, Sundararajan V, Neugut AI.

Gynecol Oncol. 2004 Jan;92(1):293-9.

PMID:
14751173
42.

Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.

Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR, Troxel A, Neugut AI.

J Natl Cancer Inst. 2003 Oct 15;95(20):1545-8.

PMID:
14559877
43.

Health insurance and cancer survival.

Grann VR, Jacobson JS.

Arch Intern Med. 2003 Oct 13;163(18):2123-4. No abstract available.

PMID:
14557205
44.

Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study.

Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI.

J Natl Cancer Inst. 2003 Feb 5;95(3):230-6.

PMID:
12569145
45.

Lung cancer screening at any price?

Grann VR, Neugut AI.

JAMA. 2003 Jan 15;289(3):357-8. No abstract available.

PMID:
12525238
46.

Population screening for cancer-related germline gene mutations.

Grann VR, Jacobson JS.

Lancet Oncol. 2002 Jun;3(6):341-8. Review.

PMID:
12107021
47.

Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study.

Neugut AI, Fleischauer AT, Sundararajan V, Mitra N, Heitjan DF, Jacobson JS, Grann VR.

J Clin Oncol. 2002 Jun 1;20(11):2643-50.

PMID:
12039925
48.

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.

Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI.

J Clin Oncol. 2002 May 15;20(10):2520-9.

PMID:
12011131
49.

Referral to medical oncologists: are there barriers at the gate?

Neugut AI, Grann VR.

J Clin Oncol. 2002 Apr 1;20(7):1716-8. No abstract available.

PMID:
11919225
50.

Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.

Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI.

Ann Intern Med. 2002 Mar 5;136(5):349-57.

PMID:
11874307

Supplemental Content

Loading ...
Support Center